Physician profile
Suleiman Ali
NPI 1316019532
$2,806.23
in general payments reported to CMS, 2019-2025
9 companies · $33.98 in 2025
The $33.98 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $564 · 2020: $15.52 · 2022: $322 · 2023: $1,871 · 2025: $33.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,337 · Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,336.80 |
| Food and Beverage | $567.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,066.02 | 2022-2023 | Da Vinci Surgical System |
| Ethicon INC. | $396.91 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $164.11 | 2019-2022 | |
| Philips North America LLC | $73.99 | 2019 | |
| Abbvie INC. | $33.98 | 2025 | |
| Amgen INC. | $20.45 | 2019 | |
| Boston Scientific Corporation | $20.30 | 2022 | |
| Veran Medical Technologies, INC. | $15.52 | 2020 | |
| Electromed, INC. | $14.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suleiman Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.